Trials / Completed
CompletedNCT03300466
A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds
A Randomized, Controlled, Evaluator-blinded, Split Face Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a study to assess the performance and safety of GP0045 when injected in the nasolabial folds. There is an 18 months follow up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GP0045 | Hyaluronic acid gel |
| DEVICE | Comparator | Hyaluronic acid gel |
Timeline
- Start date
- 2017-10-02
- Primary completion
- 2018-04-27
- Completion
- 2019-04-24
- First posted
- 2017-10-03
- Last updated
- 2022-08-26
- Results posted
- 2020-04-17
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03300466. Inclusion in this directory is not an endorsement.